NYSE American - Delayed Quote USD

Can-Fite BioPharma Ltd. (CANF)

1.0550
+0.0100
+(0.96%)
At close: May 20 at 3:59:45 PM EDT
1.0500
-0.00
(-0.47%)
Pre-Market: 4:39:56 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
674
674
743
810
853
Operating Expense
8,804
8,804
8,938
10,906
13,695
Operating Income
-8,130
-8,130
-8,195
-10,096
-12,842
Net Non Operating Interest Income Expense
277
277
492
206
6
Other Income Expense
-27
-27
69
-283
221
Pretax Income
-7,880
-7,880
-7,634
-10,173
-12,615
Tax Provision
--
--
0
0
0
Net Income Common Stockholders
-7,880
-7,880
-7,634
-10,173
-15,205
Diluted NI Available to Com Stockholders
-7,880
-7,880
-7,634
-10,173
-15,205
Basic EPS
0.00
0.00
-3.00
-3.00
-9.00
Diluted EPS
0.00
0.00
-3.00
-3.00
-9.00
Basic Average Shares
7,253.0880
7,253.0880
4,261.1130
2,719.1540
1,843.5990
Diluted Average Shares
7,253.0880
7,253.0880
4,261.1130
2,719.1540
1,843.5990
Total Operating Income as Reported
-8,130
-8,130
-8,195
-10,096
-12,842
Total Expenses
8,804
8,804
8,938
10,906
13,695
Net Income from Continuing & Discontinued Operation
-7,880
-7,880
-7,634
-10,173
-12,615
Normalized Income
-7,853
-7,853
-7,703
-9,890
-12,836
Interest Income
291
291
506
222
24
Net Interest Income
277
277
492
206
6
EBIT
-8,130
-8,130
-8,195
-10,096
-12,842
EBITDA
-8,123
-8,123
-8,180
-10,082
-12,828
Reconciled Depreciation
7
7
15
14
14
Net Income from Continuing Operation Net Minority Interest
-7,880
-7,880
-7,634
-10,173
-12,615
Total Unusual Items Excluding Goodwill
-27
-27
69
-283
221
Total Unusual Items
-27
-27
69
-283
221
Normalized EBITDA
-8,096
-8,096
-8,249
-9,799
-13,049
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/6/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BLRX BioLineRx Ltd.
3.6400
+13.40%
 
PLUR Pluri Inc.
4.8732
-1.55%
 
CHRO Channel Therapeutics Corporation
1.0300
-1.90%
 
PPBT Purple Biotech Ltd
2.4100
+3.43%
 
PYPD PolyPid Ltd.
2.9000
+3.20%
 
ENLV Enlivex Therapeutics Ltd.
0.9900
0.00%
 
EVGN Evogene Ltd.
1.2700
-7.97%
 
BONS.TA Bonus BioGroup Ltd.
23.70
+5.80%
 
MIST Milestone Pharmaceuticals Inc.
1.3900
+7.75%
 
NRSN NeuroSense Therapeutics Ltd.
1.6300
+18.12%